Strive (ASST) Stock Looks Cheap On Book Value While Cash Flow Remains Weak

Strive stock has had a very weak year, with the share price down about 84.2% over the past 12 months, while the latest valuation checks send a mixed message that includes an undervalued read on market multiples but a low overall value score.

• Over the last year, Strive has declined 84.2%, which puts recent short term gains into the context of a much larger drawdown.
• For Strive, any improvement in converting revenue into dependable cash flow can support the current share price, while pressure on profitability or a need for fresh capital may keep investors cautious about paying up.
• The stock only passes 2 of 6 valuation checks, which means Strive does not screen as a clear bargain on the broader tests even though one multiple-based measure screens it as undervalued, as shown in this valuation summary.

The issue now is whether Strive's current market price fairly reflects that weak long term share performance or still leaves room for a valuation reset.

Find out why Strive's -84.2% return over the last year is lagging behind its peers.

Is Strive a Bargain on Book Value?

P/B is often a useful cross check for asset heavy companies like Strive, because it compares the share price with the accounting value of net assets on the balance sheet. It tells you how much investors are paying for each dollar of equity.

Strive currently trades on a P/B of 1.7x. That is below the Medical Equipment industry average P/B of 2.5x and also below the broader peer group average of 5.6x. In simple terms, the market is pricing Strive’s equity at a lower multiple than many similar companies in the sector.

This gap does not automatically make Strive a bargain, because the P/B ratio does not capture loss making performance or any future funding needs. It does, however, indicate that the market is applying a discount to the stock on this balance sheet measure compared with peers.

On this measure alone, the current P/B indicates that Strive stock is valued below both its industry and peer averages.

See what the numbers say about this price — find out in our valuation breakdown.

The Strive Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Strive pick up where this valuation puzzle leaves off and explain which paths for revenue, margins and earnings would need to occur for the stock to be worth materially more or materially less than today’s price. Each narrative links its figures to a concrete view on how Strive's growth, profitability and risks might evolve. You can revisit these narratives on the Community page as new information becomes available.

You can add your voice to the Strive story by publishing a Narrative that presents your data-driven view on where its growth, margins and execution may go from here.

Set out your thesis in the Simply Wall St community and see how it compares as new results and data points are released.

Do you think there's more to the story for Strive? Head over to our Community to see what others are saying!

The Bottom Line

Strive screens as undervalued on some market multiples, including P/B, yet the broader set of valuation checks still looks weak. That kind of mixed picture often reflects investors asking for a discount until cash generation, funding needs and profitability feel more dependable. The key question for you is whether Strive can turn its current asset base and revenue into steadier cash flow. If that happens, the present discount may start to look more like an opportunity than a warning.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com